Newsroom

Newsroom

NeoGenomics Lab Operations | Hurricane Ian

Blog
Read More

PAK4 as a potential marker for poor response to immunotherapy in melanoma patients

Literature
Read More

NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022

Press Release
Read More

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release
Read More

NeoGenomics Reports Revenue of $125 Million in the Second Quarter

Press Release
Read More

NeoGenomics Announces Chief Executive Officer Appointment

Press Release
Read More

NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022

Press Release
Read More

Orphan CDx assays

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients